Current Report Filing (8-k)
June 03 2019 - 6:01AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported):
May 31
, 2019
PROPHASE
LABS, INC.
(Exact
name of registrant as specified in its charter)
Delaware
|
|
0-21617
|
|
23-2577138
|
(State
or other jurisdiction
of
incorporation)
|
|
(Commission
file
number)
|
|
(I.R.S.
Employer
Identification
No.)
|
621
N. Shady Retreat Road, Doylestown, PA, 18901
(Address
of principal executive offices)
(Registrant’s
telephone number, including area code):
(215) 345-0919
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-2)
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240. 13e-4(c))
|
Securities
Registered Pursuant to Section 12(b) of the Exchange Act:
Title
of Each Class
|
|
Trading
Symbol
|
|
Name
of Each Exchange on Which Registered
|
Common
Stock, par value $0.0005
|
|
PRPH
|
|
Nasdaq
Capital Market
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company [ ]
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
Item
8.01 Other Events
On
May 31, 2019, ProPhase Labs, Inc. (the “Company”) received written notice from Nasdaq informing the Company that it
has regained compliance with Nasdaq Listing Rule 5605(c)(2) as a result of the appointment of Mr. Warren Hirsch to the Company’s
audit committee and board of directors, as recently reported on a Current Report on Form 8-K filed with the Securities and Exchange
Commission on May 24, 2019.
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
ProPhase
Labs, Inc.
|
|
|
|
|
By:
|
/s/
Monica Brady
|
|
|
Monica
Brady
|
|
|
Chief
Financial Officer
|
Date:
June 3, 2019
ProPhase Labs (NASDAQ:PRPH)
Historical Stock Chart
From Sep 2024 to Oct 2024
ProPhase Labs (NASDAQ:PRPH)
Historical Stock Chart
From Oct 2023 to Oct 2024